Zur Kurzanzeige

2024-04-25Zeitschriftenartikel
Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023
dc.contributor.authorOtto-Knapp, Ralf
dc.contributor.authorEdwards, Suzanne
dc.contributor.authorKuchukhidze, Giorgi
dc.contributor.authorKröger, Stefan
dc.contributor.authorHäcker, Brit
dc.contributor.authorBivoli, Stela
dc.contributor.authorYedilbayev, Askar
dc.date.accessioned2026-04-27T07:59:08Z
dc.date.available2026-04-27T07:59:08Z
dc.date.issued2024-04-25none
dc.identifier.other10.2807/1560-7917.ES.2024.29.17.2400211
dc.identifier.urihttp://edoc.rki.de/176904/13672
dc.description.abstractThe BPaLM regimen (bedaquiline, pretomanid, linezolid and moxifloxacin) recently recommended by the World Health Organization offers short, safe, and effective treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB). In a survey with national TB focal points in 18 central and western European countries to explore barriers for the implementation of BPaLM, only three reported full availability of pretomanid, a necessary component of this regimen. Implementation barriers included financing and procurement. Solutions on national and supranational level are needed to guarantee universal access.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectEuropeeng
dc.subjectMDR/RR-TBeng
dc.subjectaccesseng
dc.subjectdrug availabilityeng
dc.subjectpretomanideng
dc.subjecttuberculosiseng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleAvailability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023none
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/13672-6
dc.type.versionpublishedVersionnone
local.edoc.container-titleEurosurveillance - Europe's journal on infectious disease surveillance, epidemiology, prevention and controlnone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-publisher-nameEuropean Centre for Disease Prevention and Controlnone
local.edoc.container-reportyear2024none
local.edoc.container-firstpage1none
local.edoc.container-lastpage5none
dc.description.versionPeer Reviewednone

Zur Kurzanzeige